当前位置:首页 - 行情中心 - 星昊医药(920017) - 财务分析 - 现金流量表

星昊医药

(920017)

  

流通市值:25.03亿  总市值:25.37亿
流通股本:1.23亿   总股本:1.25亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金504,051,042.5325,780,765.54160,486,306.67660,864,320.7
  收到的税费返还2,076,270.252,076,270.2534,249.621,811,048.51
  收到其他与经营活动有关的现金34,541,346.3815,985,085.334,696,005.7237,540,750.47
  经营活动现金流入小计540,668,659.13343,842,121.12165,216,562.01700,216,119.68
  购买商品、接受劳务支付的现金120,148,057.461,103,389.7825,051,170.14127,564,332.9
  支付给职工以及为职工支付的现金72,328,486.2652,144,183.4229,103,128.73105,438,808.23
  支付的各项税费48,672,396.2733,378,971.7713,106,728.3366,386,110.76
  支付其他与经营活动有关的现金215,339,660.64141,097,709.0771,700,918.29317,828,015.12
  经营活动现金流出小计456,488,600.57287,724,254.04138,961,945.49617,217,267.01
  经营活动产生的现金流量净额84,180,058.5656,117,867.0826,254,616.5282,998,852.67
二、投资活动产生的现金流量:
  收回投资收到的现金732,030,000454,030,000320,030,0002,056,000,000
  取得投资收益收到的现金5,713,573.973,399,410.962,254,534.2411,378,670.03
  处置固定资产、无形资产和其他长期资产收回的现金净额4,000---
  处置子公司及其他营业单位收到的现金净额----2,566,624.04
  收到的其他与投资活动有关的现金16,060,190.0516,060,190.0516,060,190.053,554,269.4
  投资活动现金流入小计753,807,764.02473,489,601.01338,344,724.292,068,366,315.39
  购建固定资产、无形资产和其他长期资产支付的现金40,520,134.3422,281,370.3310,987,291.1999,248,880.7
  投资支付的现金755,000,000436,000,000341,000,0001,966,030,000
  投资活动现金流出小计795,520,134.34458,281,370.33351,987,291.192,065,278,880.7
  投资活动产生的现金流量净额-41,712,370.3215,208,230.68-13,642,566.93,087,434.69
三、筹资活动产生的现金流量:
  吸收投资收到的现金33,118,470--0
  取得借款收到的现金---10,010,000
  收到其他与筹资活动有关的现金---0
  筹资活动现金流入小计33,118,4700010,010,000
  偿还债务支付的现金---10,010,000
  分配股利、利润或偿付利息支付的现金19,617,111.0319,557,055.4870,00030,664,415.54
  支付其他与筹资活动有关的现金---15,760,140.09
  筹资活动现金流出小计19,617,111.0319,557,055.4870,00056,434,555.63
  筹资活动产生的现金流量净额13,501,358.97-19,557,055.48-70,000-46,424,555.63
四、汇率变动对现金及现金等价物的影响1,100,650.571,195,239.22372,529.56-608,569.09
五、现金及现金等价物净增加额57,069,697.7852,964,281.512,914,579.1839,053,162.64
  加:期初现金及现金等价物余额413,929,487.39413,929,487.39413,929,487.39374,876,324.75
  期末现金及现金等价物余额470,999,185.17466,893,768.89426,844,066.57413,929,487.39
补充资料:
  净利润-41,083,255.36-81,632,668.88
  资产减值准备-3,068,019.01-385,137.64
  固定资产和投资性房地产折旧-23,849,129.54-44,791,366.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,849,129.54-44,791,366.4
  无形资产摊销-2,707,531.75-7,263,118.6
  长期待摊费用摊销-68,807.34-250,791.84
  固定资产报废损失---3,160.54
  公允价值变动损失--2,276,969.84--3,860,704.13
  财务费用--1,210,635.12-901,194.75
  投资损失--1,300,088.96--10,808,052.19
  递延所得税-527,169.8-5,046,476.49
  其中:递延所得税资产减少-496,951.62-4,792,064.89
    递延所得税负债增加-30,218.18-254,411.6
  存货的减少--4,349,529.71-3,003,731.08
  经营性应收项目的减少-13,929,068.77--22,690,412.22
  经营性应付项目的增加--20,832,093.09--26,976,543.07
  现金的期末余额-466,893,768.89-413,929,487.39
  减:现金的期初余额-413,929,487.39-374,876,324.75
  现金及现金等价物的净增加额-52,964,281.5-39,053,162.64
公告日期2025-10-282025-08-082025-04-282025-04-23
审计意见(境内)标准无保留意见
TOP↑